Eosinophil survival and apoptosis in health and disease

YM Park, BS Bochner - Allergy, asthma & immunology …, 2010 - synapse.koreamed.org
Eosinophilia is common feature of many disorders, including allergic diseases. There are
many factors that influence the production, migration, survival and death of the eosinophil …

Molecular mechanisms of glucocorticosteroid actions

IM Adcock - Pulmonary pharmacology & therapeutics, 2000 - Elsevier
TREATMENT OF INFLAMMATORY DISEASE important. Glucocorticosteroids inhibit the
transcription of several cytokines and chemokines that Inflammation is a central feature of …

p38 Mitogen-activated protein kinase–induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma

E Irusen, JG Matthews, A Takahashi, PJ Barnes… - Journal of Allergy and …, 2002 - Elsevier
Background: Although glucocorticoids are the most effective treatment for chronic
inflammatory diseases, such as asthma, some patients show a poor response. IL-2 …

[HTML][HTML] Asthma and chronic obstructive pulmonary disease (COPD)–differences and similarities

V Cukic, V Lovre, D Dragisic, A Ustamujic - Materia socio-medica, 2012 - ncbi.nlm.nih.gov
Bronchial asthma and COPD (chronic obstructive pulmonary disease) are obstructive
pulmonary diseases that affected millions of people all over the world. Asthma is a serious …

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised …

L Bjermer, H Bisgaard, J Bousquet, LM Fabbri… - Bmj, 2003 - bmj.com
Objectives To assess the effect of montelukast versus salmeterol added to inhaled
fluticasone propionate on asthma exacerbation in patients whose symptoms are …

Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma

RE ALDRIDGE, RJ HANCOX… - American journal of …, 2000 - atsjournals.org
Previous studies have shown that the regular administration of short acting β-agonists can
be associated with adverse effects on airway caliber and bronchial hyperresponsiveness …

Epithelial function and dysfunction in asthma

M Loxham, DE Davies, C Blume - Clinical & Experimental …, 2014 - Wiley Online Library
Asthma was previously defined as an allergic Th2‐mediated inflammatory immune disorder.
Recently, this paradigm has been challenged because not all pathological changes …

Proteinase-activated receptor-2–mediated matrix metalloproteinase-9 release from airway epithelial cells

H Vliagoftis, A Schwingshackl, CD Milne… - Journal of allergy and …, 2000 - Elsevier
Background: Matrix metalloproteinases (MMPs) digest extracellular matrix components and
might be important mediators of tissue remodeling. Proteinase activated receptor-2 (PAR-2) …

Unlocking the secrets of long non-coding RNAs in asthma

F Gysens, P Mestdagh, EB de Lavergne, T Maes - Thorax, 2022 - thorax.bmj.com
Asthma is a very heterozygous disease, divided in subtypes, such as eosinophilic and
neutrophilic asthma. Phenotyping and endotyping of patients, especially patients with …

New directions in allergic diseases: mechanism-based anti-inflammatory therapies

PJ Barnes - Journal of Allergy and Clinical Immunology, 2000 - Elsevier
Advances in our understanding of allergic inflammation have led to the development of
several novel anti-inflammatory drugs that target specific aspects of the inflammatory …